Results 11 to 20 of about 104,289 (264)

Gastroenteropancreatic neuroendocrine tumors

open access: yesЛечащий Врач
Background. Neuroendocrine tumors represent a heterogeneous group of neoplasms that vary in localization, growth characteristics, and clinical symptoms, originating from neuroendocrine cells.
V. V. Smirnov, I. D. Gurova
doaj   +3 more sources

Neuroendocrine Tumors [PDF]

open access: yesJournal of the National Comprehensive Cancer Network, 2012
Neuroendocrine tumors comprise a broad family of tumors, the most common of which are carcinoid and pancreatic neuroendocrine tumors. The NCCN Neuroendocrine Tumors Guidelines discuss the diagnosis and management of both sporadic and hereditary neuroendocrine tumors. Most of the recommendations pertain to well-differentiated, low- to intermediate-grade
Matthew H, Kulke   +27 more
openaire   +3 more sources

Gastric Neuroendocrine Tumor [PDF]

open access: yesThe Surgery Journal, 2021
AbstractGastric neuroendocrine tumor (gNET) is a rare carcinoid of the stomach whose incidence is increasing due to widespread use of upper gastrointestinal endoscopy (UGIE). There are four types of gNETs with different management strategies and prognosis. Here, we present a patient who came with abdomen pain and intermittent melena.
Naresh Kargwal   +3 more
openaire   +3 more sources

Chemotherapy in Neuroendocrine Tumors [PDF]

open access: yesCancers, 2021
The role for cytotoxic chemotherapy in patients with well-differentiated neuroendocrine tumors (NETs) remains debated. Compared to patients with poorly differentiated neuroendocrine carcinomas (NECs) where chemotherapy is utilized ubiquitously, chemotherapy may play a more select role in patients with certain types of NETs (e.g., pancreatic tumors ...
Satya Das   +2 more
openaire   +2 more sources

Neuroendocrine Tumor of the Gallbladder [PDF]

open access: yesPolish Journal of Radiology, 2015
The primary neuroendocrine tumors of the gallbladder are very rare, representing 0.2% of all neuroendocrine tumors. The definite diagnosis is incidental in most cases.A 60-year-old male patient presented with a one-month history of epigastric pain and jaundice, itching, flushing, cough and wheezing.
Monier, Ahmed   +4 more
openaire   +3 more sources

Neuroendocrine Tumors of the Thymus [PDF]

open access: yesThoracic Surgery Clinics, 2011
Neuroendocrine tumors of the thymus (NETTs) are unusual thymic neoplasms that were misdiagnosed as thymomas until the 1970s, when they eventually acquired a distinct identity. No collective large series have been published so far, and information about clinical presentation, diagnosis, histology, and treatment is derived from analysis of the case ...
RUFFINI, Enrico   +4 more
openaire   +3 more sources

Achieving objective response in treatment of non-resectable neuroendocrine tumors does not predict longer time to progression compared to achieving stable disease

open access: yesBMC Cancer, 2020
Background There are several treatment modalities for unresectable neuroendocrine tumors. Traditionally, the aim of these treatments has been to reduce the tumor load; referred to as objective response (OR).
Espen Thiis-Evensen   +3 more
doaj   +1 more source

A real-life treatment cohort of pancreatic neuroendocrine tumors: High-grade increase in metastases confers poor survival

open access: yesFrontiers in Endocrinology, 2022
BackgroundTumor grade determined by the Ki67 index is the best prognostic factor for pancreatic neuroendocrine tumors (PanNETs). However, we often observe that the grade of metastases differs from that of their primary tumors.
Wu-Hu Zhang   +60 more
doaj   +1 more source

Carcinoid Syndrome and Hyperinsulinemic Hypoglycemia Associated with Neuroendocrine Neoplasms: A Critical Review on Clinical and Pharmacological Management

open access: yesPharmaceuticals, 2021
The carcinoid syndrome (CS) and hyperinsulinemic hypoglycemia (HH) represent two of the most common clinical syndromes associated with neuroendocrine neoplasms (NENs).
Francesca Spada   +8 more
doaj   +1 more source

Updates on precision medicine of pancreatic neuroendocrine tumor [PDF]

open access: yesZhongguo aizheng zazhi, 2023
Since the concept of precision medicine proposed in 2011, the treatment of solid tumors has entered era of precision medicine led by gene testing. As a rare tumor, the incidence rate of pancreatic neuroendocrine tumor (PanNET) is increasing gradually. In
GAO Heli, XU Jin, CHEN Jie, YU Xianjun
doaj   +1 more source

Home - About - Disclaimer - Privacy